Cancer risk in a cohort of patients with systemic lupus erythematosus (SLE) in California
暂无分享,去创建一个
Richard H. White | R. Cress | R. White | Rosemary Cress | A. Parikh-Patel | Arti Parikh-Patel | Mark Allen | M. Allen
[1] D. Isenberg,et al. Is there an association of malignancy with systemic lupus erythematosus? An analysis of 276 patients under long-term review. , 2000, Rheumatology.
[2] J. Janosky,et al. Risk of malignancy in women with systemic lupus erythematosus. , 1995, The Journal of rheumatology.
[3] G. Miller,et al. Bladder leiomyosarcoma following cyclophosphamide therapy for lupus nephritis. , 1990, The Journal of urology.
[4] H. Desmurs,et al. Existe-t-il un risque particulier lié aux infections à papillomavirus chez les femmes lupiques ? , 1999 .
[5] S. Bernatsky,et al. Malignancy and systemic lupus erythematosus , 2002, Current rheumatology reports.
[6] D. Gladman,et al. How to improve morbidity and mortality in systemic lupus erythematosus. , 2000, Rheumatology.
[7] B. Armstrong,et al. Cancer in connective tissue disease. , 1982, Arthritis and rheumatism.
[8] M. Petri,et al. Risk factors for coronary artery disease in patients with systemic lupus erythematosus. , 1992, The American journal of medicine.
[9] D. Gladman,et al. Mortality studies in systemic lupus erythematosus. Results from a single center. III. Improved survival over 24 years. , 1997, The Journal of rheumatology.
[10] E. Pukkala,et al. Increased risk of cancer in patients with systemic lupus erythematosus. , 1992, Annals of the rheumatic diseases.
[11] H. Howe,et al. Increased risk of malignancy in patients with systemic lupus erythematosus. , 1998, Journal of investigative medicine : the official publication of the American Federation for Clinical Research.
[12] R Finnegan,et al. ICD-9-CM , 1986, Journal.
[13] W E Hammond,et al. Health Level 7: an application standard for electronic medical data exchange. , 1991, Topics in health record management.
[14] C. Muir,et al. International Classification of Diseases for Oncology , 1990 .
[15] D. Gladman,et al. Malignancy in systemic lupus erythematosus. , 1996, Arthritis and rheumatism.
[16] E. Zintzaras,et al. The risk of lymphoma development in autoimmune diseases: a meta-analysis. , 2005, Archives of internal medicine.
[17] A. Dawson,et al. SYSTEMIC LUPUS ERYTHEMATOSUS AND LYMPHOMA , 1978, The Lancet.
[18] D. Gladman,et al. Mortality studies in SLE: how far can we improve survival of patients with SLE. , 2004, Autoimmunity reviews.
[19] I. Bruce,et al. Detection and modification of risk factors for coronary artery disease in patients with systemic lupus erythematosus: a quality improvement study. , 1998, Clinical and experimental rheumatology.
[20] M. Liang,et al. Sensitivity and positive predictive value of Medicare Part B physician claims for rheumatologic diagnoses and procedures. , 1997, Arthritis and rheumatism.
[21] E. A.Ortiza,et al. Bladder Cancer after Cyclophosphamide Therapy for Lupus Nephritis , 2008 .
[22] S. Oertel,et al. Immunosurveillance, Immunodeficiencies and Lymphoproliferations , 2012, Recent Results in Cancer Research.
[23] J. Boivin,et al. Prevalence of factors influencing cancer risk in women with lupus: social habits, reproductive issues, and obesity. , 2002, Journal of Rheumatology.
[24] J. Dankert,et al. DO ANAEROBES CAUSE CHRONIC PROSTATITIS? , 1981, The Lancet.
[25] M. Lishner,et al. Chronic lymphocytic leukemia in a patient with systemic lupus erythematosus. , 1990, Acta Haematologica.
[26] A. Ekbom,et al. A closer look at non-Hodgkin’s lymphoma cases in a national Swedish systemic lupus erythematosus cohort: a nested case-control study , 2007, Annals of the rheumatic diseases.
[27] K. Steinsson,et al. Risk of malignancy in an unselected cohort of Icelandic patients with systemic lupus erythematosus , 2003, Lupus.
[28] A. Cohen,et al. Malignancy in a series of 70 patients with systemic lupus erythematosus. , 1974, Arthritis and rheumatism.
[29] W. Swedler,et al. Systemic lupus erythematosus and Hodgkin's lymphoma. , 1993, The Journal of rheumatology.
[30] L. Kinlen. Malignancy in autoimmune diseases. , 1992, Journal of autoimmunity.
[31] Y. Shoenfeld,et al. SLE and Cancer , 2000 .
[32] P. Lipsky,et al. Acute nonlymphocytic leukemia after treatment of systemic lupus erythematosus with immunosuppressive agents. , 1992, The Journal of rheumatology.
[33] P. Trott,et al. International Classification of Diseases for Oncology , 1977 .
[34] J. Sibley,et al. Systemic lupus erythematosus and the risk of malignancy , 2001, Lupus.
[35] J F Fries,et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. , 1982, Arthritis and rheumatism.
[36] C. Ridley,et al. Lichen sclerosus et atrophicus associated with systemic lupus erythematosus. , 1985, Journal of the American Academy of Dermatology.
[37] P. Wiernik,et al. Systemic lupus erythematosus and B-cell hematologic neoplasm , 2001, Lupus.
[38] R. Hoover,et al. Non-Hodgkin's lymphoma and other cancers among a cohort of patients with systemic lupus erythematosus. , 1997, Arthritis and rheumatism.
[39] I. Bruce,et al. Contribution of traditional risk factors to coronary artery disease in patients with systemic lupus erythematosus. , 1999, The Journal of rheumatology.
[40] D. Gladman,et al. An international cohort study of cancer in systemic lupus erythematosus. , 2005, Arthritis and rheumatism.
[41] A. Ekbom,et al. Increased cancer incidence in a Swedish cohort of patients with systemic lupus erythematosus , 2002, Scandinavian journal of rheumatology.
[42] D. Isenberg,et al. Hodgkin's lymphoma in systemic lupus erythematosus. , 2007, Rheumatology.
[43] M. Hochberg,et al. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. , 1997, Arthritis and rheumatism.
[44] A. Morley,et al. Cyclophosphamide treatment of systemic lupus erythematosus: risk of bladder cancer exceeds benefit. , 1982, British medical journal.
[45] J. Seiffert,et al. The California tumor registry: a state-of-the-art model for a regionalized, automated, population-based registry. , 1990, Topics in health record management.
[46] N. Rosenthal,et al. Myelodysplastic syndromes and acute myeloid leukemia in connective tissue disease after single-agent chemotherapy. , 1996, American journal of clinical pathology.
[47] R. Gibbons,et al. Acute nonlymphocytic leukemia following short-term, intermittent, intravenous cyclophosphamide treatment of lupus nephritis. , 1988, Arthritis and rheumatism.
[48] Deborah Melewski. Vality Technology Inc. , 1994 .
[49] O. Nived,et al. Malignancies during follow-up in an epidemiologically defined systemic lupus erythematosus inception cohort in southern Sweden , 2001, Lupus.
[50] M. Hearth-Holmes,et al. Prevalence of Active Hepatitis C Virus Infection in Patients with Systemic Lupus Erythematosus , 2001, The American journal of the medical sciences.
[51] B. de Wazières,et al. [Does a particular risk associated with papillomavirus infections exist in women with lupus?]. , 1999, La Revue de medecine interne.
[52] D. Gladman,et al. Non-Hodgkin’s lymphoma in systemic lupus erythematosus , 2005, Annals of the rheumatic diseases.
[53] Systemic lupus erythematosus in a multiethnic cohort: LUMINA XXXV. Predictive factors of high disease activity over time. , 2006, Annals of the rheumatic diseases.
[54] P. Chan,et al. Increased prevalence of squamous intraepithelial lesions in systemic lupus erythematosus: association with human papillomavirus infection. , 2004, Arthritis and rheumatism.
[55] N. Breslow,et al. Statistical methods in cancer research. Volume II--The design and analysis of cohort studies. , 1987, IARC scientific publications.
[56] D. Gladman,et al. Race/ethnicity and cancer occurrence in systemic lupus erythematosus. , 2005, Arthritis and rheumatism.
[57] O. Nived,et al. Incidence studies of systemic lupus erythematosus in Southern Sweden: increasing age, decreasing frequency of renal manifestations and good prognosis. , 2000, The Journal of rheumatology.
[58] C. Pineau,et al. Cancer screening in patients with systemic lupus erythematosus. , 2006, The Journal of rheumatology.
[59] N. Taub,et al. Environmental factors predicting nephritis in systemic lupus erythematosus. , 1993, Annals of the rheumatic diseases.
[60] H. Riess,et al. Immunosurveillance, immunodeficiency and lymphoproliferations. , 2002, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.